...
Continue reading >>Vaccine stocks continue to explode higher. Moderna (MRNA) has now from $72 to $172, as it nears its meeting with the US FDA on Dec. 17 with regards to emergency use authorization. BioNTech (BNTX) has run from $90 to $130 a share, as it also nears emergency use authorization with the US FDA. Even Pfizer (PFE) has run from $35 to $43. We’d like to see the PFE stock closer to $50 a share...
Continue reading >>...
Continue reading >>The stock market closed higher on Friday despite a disappointing jobs report as Wall Street remained focused on positive vaccine developments and growing hopes for more fiscal stimulus before yearend. The gains lifted all four of the major indexes to fresh all-time highs, along with the Transports, with volatility continuing to hold a key level of support. The Russell 2000 finished on its...
Continue reading >>After investors spent a decade pouring money into Silicon Valley start-ups so they could keep growing while staying private, the pendulum has completely swung around, and tech IPOs are bigger than ever.Three of the 10 biggest tech IPOs for U.S. companies, in terms of capital raised, have taken place this year. Two happened on consecutive days in the last week, when DoorDash and Airbnb started...
Continue reading >>The stock market closed higher on Friday despite a disappointing jobs report as Wall Street remained focused on positive vaccine developments and growing hopes for more fiscal stimulus before yearend. The gains lifted all four of the major indexes to fresh all-time highs, along with the Transports, with volatility continuing to hold a key level of support. The Russell 2000 finished on its...
Continue reading >>